TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive NCI FY94 Budget To Fund 860 Grants, Increase Prevention, Construction Money December 3, 1993
TCL Archive NCI’s Frei & Freireich era Lauded As Researchers Receive First NIH Distinguished Alumni Award September 14, 1990